Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

CCR Translations

  • CCR Translations
    Proliferation Imaging to Measure Early Cancer Response to Targeted Therapy
    David A. Mankoff and Janet F. Eary
    Clin Cancer Res November 15 2008 14 (22) 7159-7160; DOI:10.1158/1078-0432.CCR-08-2233

Molecular Pathways

  • Molecular Pathways
    Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
    Jochen Greiner, Lars Bullinger, Barbara-ann Guinn, Hartmut Döhner and Michael Schmitt
    Clin Cancer Res November 15 2008 14 (22) 7161-7166; DOI:10.1158/1078-0432.CCR-08-1102

  • Molecular Pathways
    Microtubule Active Agents: Beyond the Taxane Frontier
    Patrick G. Morris and Monica N. Fornier
    Clin Cancer Res November 15 2008 14 (22) 7167-7172; DOI:10.1158/1078-0432.CCR-08-0169

Human Cancer Biology

  • Human Cancer Biology
    Human Telomerase Reverse Transcriptase Activated by E6 Oncoprotein Is Required for Human Papillomavirus-16/18-Infected Lung Tumorigenesis
    Ya-Wen Cheng, Tzu-Chin Wu, Chih-Yi Chen, Ming-Chih Chou, Jiunn-Liang Ko and Huei Lee
    Clin Cancer Res November 15 2008 14 (22) 7173-7179; DOI:10.1158/1078-0432.CCR-08-0850

  • Human Cancer Biology
    Clonal Evolution in t(14;18)-Positive Follicular Lymphoma, Evidence for Multiple Common Pathways, and Frequent Parallel Clonal Evolution
    Francesco d'Amore, Eric Chan, Javeed Iqbal, Huimin Geng, Ken Young, Li Xiao, Michelle M. Hess, Warren G. Sanger, Lynette Smith, Carsten Wiuf, Oskar Hagberg, Kai Fu, Wing C. Chan and Bhavana J. Dave
    Clin Cancer Res November 15 2008 14 (22) 7180-7187; DOI:10.1158/1078-0432.CCR-08-0752

  • Human Cancer Biology
    Surgery followed by Persistence of High-Grade Squamous Intraepithelial Lesions Is Associated with the Induction of a Dysfunctional HPV16-Specific T-Cell Response
    Peggy J. de Vos van Steenwijk, Sytse J. Piersma, Marij J.P. Welters, Jeanette M. van der Hulst, Gertjan Fleuren, Bart W.J. Hellebrekers, Gemma G. Kenter and Sjoerd H. van der Burg
    Clin Cancer Res November 15 2008 14 (22) 7188-7195; DOI:10.1158/1078-0432.CCR-08-0994

  • Human Cancer Biology
    Role of the Erythropoietin Receptor in ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia
    Andrea Inthal, Gerd Krapf, Dominik Beck, Ruth Joas, Max O. Kauer, Lukas Orel, Gerhard Fuka, Georg Mann and E. Renate Panzer-Grümayer
    Clin Cancer Res November 15 2008 14 (22) 7196-7204; DOI:10.1158/1078-0432.CCR-07-5051

  • Human Cancer Biology
    Vascular Endothelial Growth Factor C Stimulates Progression of Human Gastric Cancer via Both Autocrine and Paracrine Mechanisms
    Michiyo Kodama, Yasuhiko Kitadai, Miwako Tanaka, Toshio Kuwai, Shinji Tanaka, Naohide Oue, Wataru Yasui and Kazuaki Chayama
    Clin Cancer Res November 15 2008 14 (22) 7205-7214; DOI:10.1158/1078-0432.CCR-08-0818

  • Human Cancer Biology
    Identification of the Molecular Mechanisms for Dedifferentiation at the Invasion Front of Colorectal Cancer by a Gene Expression Analysis
    Yoshimasa Oku, Takashi Shimoji, Katsunari Takifuji, Tsukasa Hotta, Shozo Yokoyama, Kenji Matsuda, Takashi Higashiguchi, Toshiji Tominaga, Toru Nasu, Koichi Tamura, Masaaki Matsuura, Satoshi Miyata, Yo Kato, Hiroki Yamaue and Yoshio Miki
    Clin Cancer Res November 15 2008 14 (22) 7215-7222; DOI:10.1158/1078-0432.CCR-08-0370

  • Human Cancer Biology
    Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
    Cecile Rouleau, Maritza Curiel, William Weber, Robert Smale, Leslie Kurtzberg, James Mascarello, Carol Berger, Gina Wallar, Rebecca Bagley, Nakayuki Honma, Kazumasa Hasegawa, Isao Ishida, Shiro Kataoka, Beth L. Thurberg, Khodadad Mehraein, Bruce Horten, Glenn Miller and Beverly A. Teicher
    Clin Cancer Res November 15 2008 14 (22) 7223-7236; DOI:10.1158/1078-0432.CCR-08-0499

  • Human Cancer Biology
    Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer
    Arnaud Van Den Broeck, Elisabeth Brambilla, Denis Moro-Sibilot, Sylvie Lantuejoul, Christian Brambilla, Beatrice Eymin, Saadi Khochbin and Sylvie Gazzeri
    Clin Cancer Res November 15 2008 14 (22) 7237-7245; DOI:10.1158/1078-0432.CCR-08-0869

  • Human Cancer Biology
    Genetic Analysis of Cancer-Implicated MicroRNA in Ovarian Cancer
    Jennifer L. Bearfoot, David Y.H. Choong, Kylie L. Gorringe and Ian G. Campbell
    Clin Cancer Res November 15 2008 14 (22) 7246-7250; DOI:10.1158/1078-0432.CCR-08-1348

  • Human Cancer Biology
    Overexpression of Indoleamine 2,3-Dioxygenase in Human Endometrial Carcinoma Cells Induces Rapid Tumor Growth in a Mouse Xenograft Model
    Norio Yoshida, Kazuhiko Ino, Yoshiyuki Ishida, Hiroaki Kajiyama, Eiko Yamamoto, Kiyosumi Shibata, Mikio Terauchi, Akihiro Nawa, Hidetoshi Akimoto, Osamu Takikawa, Ken-ichi Isobe and Fumitaka Kikkawa
    Clin Cancer Res November 15 2008 14 (22) 7251-7259; DOI:10.1158/1078-0432.CCR-08-0991

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin
    Jennifer H.E. Baker, Jeffrey Lam, Alaistair H. Kyle, Jonathan Sy, Thomas Oliver, Steven J. Co, Wieslawa H. Dragowska, Euan Ramsay, Malathi Anantha, Thomas J. Ruth, Michael J. Adam, Andrew Yung, Piotr Kozlowski, Andrew I. Minchinton, Sylvia S.W. Ng, Marcel B. Bally and Donald T.T. Yapp
    Clin Cancer Res November 15 2008 14 (22) 7260-7271; DOI:10.1158/1078-0432.CCR-08-0736

  • Cancer Therapy: Preclinical
    Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
    Dana D. Hu-Lowe, Helen Y. Zou, Maren L. Grazzini, Max E. Hallin, Grant R. Wickman, Karin Amundson, Jeffrey H. Chen, David A. Rewolinski, Shinji Yamazaki, Ellen Y. Wu, Michele A. McTigue, Brion W. Murray, Robert S. Kania, Patrick O'Connor, David R. Shalinsky and Steve L. Bender
    Clin Cancer Res November 15 2008 14 (22) 7272-7283; DOI:10.1158/1078-0432.CCR-08-0652

  • Cancer Therapy: Preclinical
    G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors
    Carlo Leonetti, Marco Scarsella, Giuseppe Riggio, Angela Rizzo, Erica Salvati, Maurizio D'Incalci, Lidia Staszewsky, Roberta Frapolli, Malcolm F. Stevens, Antonella Stoppacciaro, Marcella Mottolese, Barbara Antoniani, Eric Gilson, Gabriella Zupi and Annamaria Biroccio
    Clin Cancer Res November 15 2008 14 (22) 7284-7291; DOI:10.1158/1078-0432.CCR-08-0941

  • Cancer Therapy: Preclinical
    Induction of Both CD8+ and CD4+ T-Cell–Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1
    Cristina Maccalli, Veronica Di Cristanziano, Valentina Fodale, Domenico Corsi, Giuseppina D'Agostino, Valentina Petrangeli, Luca Laurenti, Sofia Guida, Arabella Mazzocchi, Flavio Arienti, Maria P. Perrone, Chiara Castelli, Licia Rivoltini, Vittorina Zagonel, Marco Tartaglia, Giorgio Parmiani and Filippo Belardelli
    Clin Cancer Res November 15 2008 14 (22) 7292-7303; DOI:10.1158/1078-0432.CCR-08-0832

  • Cancer Therapy: Preclinical
    Circulating Biomarkers of Cell Death After Treatment with the BH-3 Mimetic ABT-737 in a Preclinical Model of Small-Cell Lung Cancer
    Dimitra Micha, Jeff Cummings, Alex Shoemaker, Steven Elmore, Kelly Foster, Martin Greaves, Tim Ward, Saul Rosenberg, Caroline Dive and Kathryn Simpson
    Clin Cancer Res November 15 2008 14 (22) 7304-7310; DOI:10.1158/1078-0432.CCR-08-0111

  • Cancer Therapy: Preclinical
    Preferential Tumor Targeting and Selective Tumor Cell Cytotoxicity of 5-[131/125I]Iodo-4′-Thio-2′-Deoxyuridine
    Agnieszka Morgenroth, Sandra Deisenhofer, Gerhard Glatting, Falk H-G. Kunkel, Cornelia Dinger, Boris Zlatopolskiy, Andreas T.J. Vogg, Thomas Kull and Sven N. Reske
    Clin Cancer Res November 15 2008 14 (22) 7311-7319; DOI:10.1158/1078-0432.CCR-08-0907

  • Cancer Therapy: Preclinical
    Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
    Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, Beatrice Nico, Domenico Ribatti, Antonio Daga, Gabriella Baio, Carlo E. Neumaier, Chiara Brignole, Monica Loi, Danilo Marimpietri, Gabriella Pagnan, Michele Cilli, Eugene A. Lepekhin, Seema V. Garde, Renato Longhi, Angelo Corti, Theresa M. Allen, Jinzi J. Wu and Mirco Ponzoni
    Clin Cancer Res November 15 2008 14 (22) 7320-7329; DOI:10.1158/1078-0432.CCR-08-0804

  • Cancer Therapy: Preclinical
    Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme
    Anand Veeravagu, Zhaofei Liu, Gang Niu, Kai Chen, Bing Jia, Weibo Cai, Cunjing Jin, Andrew R. Hsu, Andrew J. Connolly, Victor Tse, Fan Wang and Xiaoyuan Chen
    Clin Cancer Res November 15 2008 14 (22) 7330-7339; DOI:10.1158/1078-0432.CCR-08-0797

  • Cancer Therapy: Preclinical
    Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor
    Martina Bazzaro, Zhenhua Lin, Antonio Santillan, Michael K. Lee, Mei-Cheng Wang, Kwun C. Chan, Robert E. Bristow, Ralph Mazitschek, James Bradner and Richard B.S. Roden
    Clin Cancer Res November 15 2008 14 (22) 7340-7347; DOI:10.1158/1078-0432.CCR-08-0642

  • Cancer Therapy: Preclinical
    An Orthotopic Murine Model of Sinonasal Malignancy
    Alexander Gelbard, Michael E. Kupferman, Samar A. Jasser, Wantao Chen, Adel K. El-Naggar, Jeffrey N. Myers and Ehab Y. Hanna
    Clin Cancer Res November 15 2008 14 (22) 7348-7357; DOI:10.1158/1078-0432.CCR-08-0977

  • Cancer Therapy: Preclinical
    Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
    Robin J. Prestwich, Fiona Errington, Elizabeth J. Ilett, Ruth S.M. Morgan, Karen J. Scott, Timothy Kottke, Jill Thompson, Ewan E. Morrison, Kevin J. Harrington, Hardev S. Pandha, Peter J. Selby, Richard G. Vile and Alan A. Melcher
    Clin Cancer Res November 15 2008 14 (22) 7358-7366; DOI:10.1158/1078-0432.CCR-08-0831

  • Cancer Therapy: Preclinical
    Diabodies Targeting Epithelial Membrane Protein 2 Reduce Tumorigenicity of Human Endometrial Cancer Cell Lines
    Kaori Shimazaki, Eric J. Lepin, Bo Wei, Agnes K. Nagy, Catherine P. Coulam, Sergey Mareninov, Maoyong Fu, Anna M. Wu, James D. Marks, Jonathan Braun, Lynn K. Gordon and Madhuri Wadehra
    Clin Cancer Res November 15 2008 14 (22) 7367-7377; DOI:10.1158/1078-0432.CCR-08-1016

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Loss of Nuclear p27 Expression and Its Prognostic Role in Relation to Cyclin E and p53 Mutation in Gastroenteropancreatic Neuroendocrine Tumors
    Patricia Grabowski, Jörg Schrader, Julia Wagner, Dieter Hörsch, Rudolf Arnold, Christian N. Arnold, Inna Georgieva, Harald Stein, Martin Zeitz, Peter T. Daniel and Isrid Sturm
    Clin Cancer Res November 15 2008 14 (22) 7378-7384; DOI:10.1158/1078-0432.CCR-08-0698

  • Imaging, Diagnosis, Prognosis
    Predictive Value of Plasma Hepatocyte Growth Factor/Scatter Factor Levels in Patients with Clinically Localized Prostate Cancer
    Amit Gupta, Pierre I. Karakiewicz, Claus G. Roehrborn, Yair Lotan, Alexandre R. Zlotta and Shahrokh F. Shariat
    Clin Cancer Res November 15 2008 14 (22) 7385-7390; DOI:10.1158/1078-0432.CCR-07-5110

  • Imaging, Diagnosis, Prognosis
    Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial
    Kazuo Koyanagi, Anton J. Bilchik, Sukamal Saha, Roderick R. Turner, David Wiese, Martin McCarter, Perry Shen, Linda Deacon, David Elashoff and Dave S.B. Hoon
    Clin Cancer Res November 15 2008 14 (22) 7391-7396; DOI:10.1158/1078-0432.CCR-08-0290

  • Imaging, Diagnosis, Prognosis
    Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression
    Eung-Sirk Lee, Dae-Soon Son, Sung-Hyun Kim, Jinseon Lee, Jisuk Jo, Joungho Han, Heesue Kim, Hyun Joo Lee, Hye Young Choi, Youngja Jung, Miyeon Park, Yu Sung Lim, Kwhanmien Kim, Young Mog Shim, Byung Chul Kim, Kyusang Lee, Nam Huh, Christopher Ko, Kyunghee Park, Jae Won Lee, Yong Soo Choi and Jhingook Kim
    Clin Cancer Res November 15 2008 14 (22) 7397-7404; DOI:10.1158/1078-0432.CCR-07-4937

  • Imaging, Diagnosis, Prognosis
    Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma
    Bin Lu, Yunchao Ma, Guobin Wu, Xin Tong, Huaizu Guo, Anmin Liang, Wenming Cong, Chang Liu, Hao Wang, Mengchao Wu, Jian Zhao and Yajun Guo
    Clin Cancer Res November 15 2008 14 (22) 7405-7412; DOI:10.1158/1078-0432.CCR-08-0409

  • Imaging, Diagnosis, Prognosis
    Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer
    H. Charles Manning, Nipun B. Merchant, A. Coe Foutch, John M. Virostko, Shelby K. Wyatt, Chirayu Shah, Eliot T. McKinley, Jingping Xie, Nathan J. Mutic, M. Kay Washington, Bonnie LaFleur, Mohammed Noor Tantawy, Todd E. Peterson, M. Sib Ansari, Ronald M. Baldwin, Mace L. Rothenberg, Darryl J. Bornhop, John C. Gore and Robert J. Coffey
    Clin Cancer Res November 15 2008 14 (22) 7413-7422; DOI:10.1158/1078-0432.CCR-08-0239

  • Imaging, Diagnosis, Prognosis
    [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung
    Hee-Jung Sohn, You-Jung Yang, Jin-Sook Ryu, Seung Jun Oh, Ki Chun Im, Dae Hyuk Moon, Dae Ho Lee, Cheolwon Suh, Jung-Shin Lee and Sang-We Kim
    Clin Cancer Res November 15 2008 14 (22) 7423-7429; DOI:10.1158/1078-0432.CCR-08-0312

  • Imaging, Diagnosis, Prognosis
    Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer
    Alex Soltermann, Verena Tischler, Stefanie Arbogast, Julia Braun, Nicole Probst-Hensch, Walter Weder, Holger Moch and Glen Kristiansen
    Clin Cancer Res November 15 2008 14 (22) 7430-7437; DOI:10.1158/1078-0432.CCR-08-0935

  • Imaging, Diagnosis, Prognosis
    Quantitative Analysis of Vascular Endothelial Growth Factor in Liver Metastases from Pancreatic Carcinoma as a Predictor of Chemotherapeutic Effect and Prognosis
    Katsunobu Tawada, Takeshi Ishihara, Akitoshi Kobayashi, Taketo Yamaguchi, Toshio Tsuyuguchi, Masato Matsuyama and Osamu Yokosuka
    Clin Cancer Res November 15 2008 14 (22) 7438-7443; DOI:10.1158/1078-0432.CCR-07-4980

  • Imaging, Diagnosis, Prognosis
    Relationship Between Tumor and Plasma Levels of hTERT mRNA in Patients with Colorectal Cancer: Implications for Monitoring of Neoplastic Disease
    Liliana Terrin, Enrica Rampazzo, Salvatore Pucciarelli, Marco Agostini, Roberta Bertorelle, Giovanni Esposito, Paola DelBianco, Donato Nitti and Anita De Rossi
    Clin Cancer Res November 15 2008 14 (22) 7444-7451; DOI:10.1158/1078-0432.CCR-08-0478

  • Imaging, Diagnosis, Prognosis
    Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer
    Steven Van Laere, Tim Beissbarth, Ilse Van der Auwera, Gert Van den Eynden, Xuan Bich Trinh, Hilde Elst, Paul Van Hummelen, Peter van Dam, Eric Van Marck, Peter Vermeulen and Luc Dirix
    Clin Cancer Res November 15 2008 14 (22) 7452-7460; DOI:10.1158/1078-0432.CCR-08-1077

  • Imaging, Diagnosis, Prognosis
    Monoclonal Antibody CC188 Binds a Carbohydrate Epitope Expressed on the Surface of Both Colorectal Cancer Stem Cells and their Differentiated Progeny
    Mai Xu, Yuan Yuan, Yang Xia and Samuel Achilefu
    Clin Cancer Res November 15 2008 14 (22) 7461-7469; DOI:10.1158/1078-0432.CCR-07-4430

  • Imaging, Diagnosis, Prognosis
    Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression
    Giancarlo Castellano, Grazia Malaponte, Maria C. Mazzarino, Mariangela Figini, Francesco Marchese, Pietro Gangemi, Salvatore Travali, Franca Stivala, Silvana Canevari and Massimo Libra
    Clin Cancer Res November 15 2008 14 (22) 7470-7480; DOI:10.1158/1078-0432.CCR-08-0870

  • Imaging, Diagnosis, Prognosis
    The Use of Genetic Markers to Identify Lung Cancer in Fine Needle Aspiration Samples
    Rajbir K. Gill, Madeline F. Vazquez, Arin Kramer, Megan Hames, Lijuan Zhang, Kerstin Heselmeyer-Haddad, Thomas Ried, Konstantin Shilo, Claudia Henschke, David Yankelevitz and Jin Jen
    Clin Cancer Res November 15 2008 14 (22) 7481-7487; DOI:10.1158/1078-0432.CCR-07-5242

  • Imaging, Diagnosis, Prognosis
    Humanized Radioiodinated Minibody For Imaging of Prostate Stem Cell Antigen–Expressing Tumors
    Jeffrey V. Leyton, Tove Olafsen, Eric J. Lepin, Scott Hahm, Karl B. Bauer, Robert E. Reiter and Anna M. Wu
    Clin Cancer Res November 15 2008 14 (22) 7488-7496; DOI:10.1158/1078-0432.CCR-07-5093

  • Imaging, Diagnosis, Prognosis
    The N Staging System in Nasopharyngeal Carcinoma with Radiation Therapy Oncology Group Guidelines for Lymph Node Levels Based on Magnetic Resonance Imaging
    Yan-Ping Mao, Shao-Bo Liang, Li-Zhi Liu, Yong Chen, Ying Sun, Ling-Long Tang, Li Tian, Ai-Hua Lin, Meng-Zhong Liu, Li Li and Jun Ma
    Clin Cancer Res November 15 2008 14 (22) 7497-7503; DOI:10.1158/1078-0432.CCR-08-0271

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Vaccination of Renal Cell Cancer Patients with Modified Vaccinia Ankara Delivering Tumor Antigen 5T4 (TroVax) Administered with Interleukin 2: A Phase II Trial
    Robert J. Amato, William Shingler, Stuart Naylor, Jaroslaw Jac, James Willis, Somyata Saxena, Joan Hernandez-McClain and Richard Harrop
    Clin Cancer Res November 15 2008 14 (22) 7504-7510; DOI:10.1158/1078-0432.CCR-08-0668

  • Cancer Therapy: Clinical
    Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt
    Gustavo Ayala, Jun Yan, Rile Li, Yi Ding, Timothy C. Thompson, Martha P. Mims, Teresa G. Hayes, Vivian MacDonnell, R. Garret Lynch, Anna Frolov, Brian J. Miles, Thomas M. Wheeler, J. Wade Harper, Ming-Jer Tsai, Michael M. Ittmann and Dov Kadmon
    Clin Cancer Res November 15 2008 14 (22) 7511-7518; DOI:10.1158/1078-0432.CCR-08-0839

  • Cancer Therapy: Clinical
    Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma
    James Bean, Gregory J. Riely, Marissa Balak, Jenifer L. Marks, Marc Ladanyi, Vincent A. Miller and William Pao
    Clin Cancer Res November 15 2008 14 (22) 7519-7525; DOI:10.1158/1078-0432.CCR-08-0151

  • Cancer Therapy: Clinical
    Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors
    Sarah A. Lowndes, Avril Adams, Anthony Timms, Nita Fisher, Jon Smythe, Suzanne M. Watt, Simon Joel, Fernando Donate, Carolyn Hayward, Steven Reich, Mark Middleton, Andrew Mazar and Adrian L. Harris
    Clin Cancer Res November 15 2008 14 (22) 7526-7534; DOI:10.1158/1078-0432.CCR-08-0315

  • Cancer Therapy: Clinical
    Clinical and Pharmacologic Study of the Novel Prodrug Delimotecan (MEN 4901/T-0128) in Patients with Solid Tumors
    Stephan A. Veltkamp, Els O. Witteveen, Angela Capriati, Attilio Crea, Fabio Animati, Marja Voogel-Fuchs, Ingeborg J.G.M. van den Heuvel, Jos H. Beijnen, Emile E. Voest and Jan H.M. Schellens
    Clin Cancer Res November 15 2008 14 (22) 7535-7544; DOI:10.1158/1078-0432.CCR-08-0438

  • Cancer Therapy: Clinical
    Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer
    Wolfgang Walther, Robert Siegel, Dennis Kobelt, Thomas Knösel, Manfred Dietel, Andreas Bembenek, Jutta Aumann, Martin Schleef, Ruth Baier, Ulrike Stein and Peter M. Schlag
    Clin Cancer Res November 15 2008 14 (22) 7545-7553; DOI:10.1158/1078-0432.CCR-08-0412

  • Cancer Therapy: Clinical
    Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
    Anne M. Schultheis, Georg Lurje, Katrin E. Rhodes, Wu Zhang, Dongyun Yang, Agustin A. Garcia, Robert Morgan, David Gandara, Sidney Scudder, Amit Oza, Hal Hirte, Gini Fleming, Lynda Roman and Heinz-Josef Lenz
    Clin Cancer Res November 15 2008 14 (22) 7554-7563; DOI:10.1158/1078-0432.CCR-08-0351

  • Cancer Therapy: Clinical
    Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
    Roger K. Strair, Mecide Gharibo, Dale Schaar, Arnold Rubin, Jonathan Harrison, Joseph Aisner, Hsin-Ching Lin, Yong Lin, Lauri Goodell, Monika Anand, Binaifer Balsara, Liesel Dudek, Arnold Rabson and Daniel J. Medina
    Clin Cancer Res November 15 2008 14 (22) 7564-7568; DOI:10.1158/1078-0432.CCR-08-1390

Cancer Prevention and Susceptibility

  • Cancer Prevention and Susceptibility
    High Risk for Ovarian Cancer in a Prospective Series Is Restricted to BRCA1/2 Mutation Carriers
    Lovise Mæhle, Jaran Apold, Torbjørn Paulsen, Bjørn Hagen, Kjell Løvslett, Bent Fiane, Marijke Van Ghelue, Neal Clark and Pål Møller
    Clin Cancer Res November 15 2008 14 (22) 7569-7573; DOI:10.1158/1078-0432.CCR-08-0112

Letters to the Editor

  • Letters to the Editor
    Ovarian Cancer Early Detection Claims Are Biased
    Martin McIntosh, Garnet Anderson, Charles Drescher, Samir Hanash, Nicole Urban, Pat Brown, Sanjiv Sam Gambhir, George Coukos, Peter W. Laird, Brad Nelson and Chana Palmer
    Clin Cancer Res November 15 2008 14 (22) 7574-7574; DOI:10.1158/1078-0432.CCR-08-0623

  • Letters to the Editor
    The Importance of Test Positive Predictive Value in Ovarian Cancer Screening
    Mark H. Greene, Ziding Feng and Mitchell H. Gail
    Clin Cancer Res November 15 2008 14 (22) 7574-7574; DOI:10.1158/1078-0432.CCR-08-2232

  • Letters to the Editor
    Diagnostic Markers for Ovarian Cancer Screening: Not Ready for Routine Clinical Use
    Ralph J. Coates, Katherine Kolor, Sherri L. Stewart and Lisa C. Richardson
    Clin Cancer Res November 15 2008 14 (22) 7575-7576; DOI:10.1158/1078-0432.CCR-08-2296

  • Letters to the Editor
    Reply to the Letters to the Editor from Greene et al.
    Gil Mor, Peter E. Schwartz and Herbert Yu
    Clin Cancer Res November 15 2008 14 (22) 7577-7579; DOI:10.1158/1078-0432.CCR-08-2621

  • Letters to the Editor
    Myelotoxicity in Cancer Patients Treated with Chemotherapy: Negative or Positive Prognostic Factor?
    Angelos K. Koutras and Haralabos P. Kalofonos
    Clin Cancer Res November 15 2008 14 (22) 7579-7579; DOI:10.1158/1078-0432.CCR-08-1519

Back to top
PreviousNext
Clinical Cancer Research: 14 (22)
November 2008
Volume 14, Issue 22
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
  • Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
  • Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors
  • Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor

Jump to

  • CCR Translations
  • Molecular Pathways
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Prevention and Susceptibility
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • Targeted TNF Potentiates the Efficacy of a Peptide Vaccine
  • WNT/β-catenin–Associated Immune Exclusion across Cancers
  • Alisertib for Neuroendocrine Prostate Cancer
  • Genotyping of HCC in the Clinic
  • Single-Cell RNA Sequencing of Pancreatic Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement